RNAZ logo

RNAZ
TransCode Therapeutics Inc

7,474
Mkt Cap
$11.16M
Volume
0.00
52W High
$568.26
52W Low
$6.15
PE Ratio
-0.04
RNAZ Fundamentals
50D MA
$11.56
Beta
1.81
Avg. Volume
12,028.71
EPS (Annual)
-$1,317.38
P/B
1.82
Rev/Employee
$0.00
Loading...
Loading...
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7

Frequently Asked Questions

What is Market Cap of TransCode Therapeutics Inc?
What is the 52-week high for TransCode Therapeutics Inc?
What is the 52-week low for TransCode Therapeutics Inc?
What is the PE ratio of TransCode Therapeutics Inc?
What is the Price-to-Book ratio of TransCode Therapeutics Inc?
What is the 50-day moving average of TransCode Therapeutics Inc?
How many employess does TransCode Therapeutics Inc has?

Latest RNAZ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.